References
-
1) S100A9 promotes glycolytic activity in HER2-positive breast cancer to induce immunosuppression in the tumour microenvironment.
-
2) The Cytomegalovirus M35 Protein Directly Binds to the Interferon-β Enhancer and Modulates Transcription of Ifnb1 and Other IRF3-Driven Genes.
-
3) Phlorizin ameliorates myocardial fibrosis by inhibiting pyroptosis through restraining HK1-mediated NLRP3 inflammasome activation.
-
4) Exploring the mechanism of Liuwei Dihuang formula for promoting melanin synthesis in juvenile zebrafish based on network pharmacology and molecular docking.
-
5) The role of lysosomes as intermediates in betacoronavirus PHEV egress from nerve cells.
-
6) Multi-omics analysis of fecal microbiota transplantation's impact on functional constipation and comorbid depression and anxiety.
-
7) The downregulation of miR-509-3p expression by collagen type XI alpha 1-regulated hypermethylation facilitates cancer progression and chemoresistance via the DNA methyltransferase 1/Small ubiquitin-like modifier-3 axis in ovarian cancer cells.
-
8) Puerarin inhibits inflammation and lipid accumulation in alcoholic liver disease through regulating MMP8.
-
9) HGF Secreted by Menstrual Blood-Derived Endometrial Stem Cells Ameliorates Non-Alcoholic Fatty Liver Disease Through Downregulation of Hepatic Rnf186.
-
10) A2BR facilitates the pathogenesis of H. pylori-associated GU by inducing oxidative stress through p38 MAPK phosphorylation.
-
11) Paeonol reduces microbial metabolite α-hydroxyisobutyric acid to alleviate the ROS/TXNIP/NLRP3 pathway-mediated endothelial inflammation in atherosclerosis mice.
-
12) Apolipoprotein E (ApoE) orchestrates adipose tissue inflammation and metabolic disorders through NLRP3 inflammasome.
-
13) OPG gene-modified adipose-derived stem cells improve bone formation around implants in osteoporotic rat maxillae.
-
14) TRPM2 exacerbates airway inflammation by regulating oxidized-CaMKⅡ in allergic asthma.
-
15) Ellagic acid inhibits tumor growth and potentiates the therapeutic efficacy of sorafenib in hepatocellular carcinoma.